Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer.
Bajetta E, Biganzoli L, Carnaghi C, Di Bartolomeo M, Spagnoli I, Cassata A, Galante E, Mariani L, Stampino CG, Buzzoni R.
Bajetta E, et al.
Cancer. 1998 Sep 15;83(6):1136-41. doi: 10.1002/(sici)1097-0142(19980915)83:6<1136::aid-cncr12>3.0.co;2-6.
Cancer. 1998.
PMID: 9740078
Clinical Trial.
The objective of this Phase II trial was to evaluate the effectiveness and tolerability of oral 5-dFUR, biomodulated with levoleucovorin (1-leucovorin), in elderly patients (age > 70 years) with ABC. ...
The objective of this Phase II trial was to evaluate the effectiveness and tolerability of oral 5-dFUR, biomodulated with levoleucovorin …